Federal Agency · Food and Drug Administration
Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)
Last updated: November 8, 2026
Posted November 24, 2023
- Who can apply
- Government agencies and municipalities, tribal governments and Native American organizations, educational institutions, and for-profit businesses
- Amount
- $250K
- Deadline
- Rolling
- Where
- Nationwide
- Status
- Rolling — no fixed deadline
Food and Drug Administration is a federal agency that offers the Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required) grant program to support eligible programs and projects. This funding opportunity is available nationally and is administered by Food and Drug Administration through Grants.gov. Organizations seeking funding for eligible programs and projects should review the details below and confirm their eligibility before preparing an application.
Eligibility
Eligible applicants include government agencies and municipalities, tribal governments and Native American organizations, educational institutions, and for-profit businesses. Organizations that meet the eligibility criteria are encouraged to apply and to review the full program guidelines before submission. Because eligibility rules and funding priorities can change between cycles, applicants should always confirm the current requirements with Food and Drug Administration or on Grants.gov before investing time in an application.
Funding and Timeline
Funding available: $250K. This is a rolling or open-cycle opportunity with no fixed application deadline. Applicants should allow sufficient time to gather required documentation, including organizational information, project descriptions, budgets, and supporting materials as specified in the program guidelines. Submitting a complete application well ahead of the deadline reduces the risk of disqualification on technical or administrative grounds.
Program Focus
This grant supports eligible programs and projects. This grant is associated with NAICS industry classifications: 541714, 325412. Organizations operating in these sectors are encouraged to review eligibility. Funded projects are expected to demonstrate measurable outcomes aligned with the program's stated objectives. Grant recipients may be required to submit progress reports and final evaluations as a condition of the award, and to retain records for audit and compliance purposes.
How to Apply
Eligible organizations can apply through Grants.gov. Create a free organization profile on GrantRegister to see whether this grant matches your organization's NAICS code, entity type, location, and focus area, and to receive a weekly digest of every open grant you qualify for. GrantRegister maintains a complete, authoritative registry of US federal, state, and foundation grant opportunities — matched automatically to your organization profile and delivered every Monday.
Focus area
- Funded by FDA
NAICS: 541714, 325412
Award details
Award range: $250K.
Categories
Not categorized
Grants.gov ↗·Last verified November 8, 2026
Similar grants
- Balanced Prosecution of Transnational Organized Crime CasesBureau of International Narcotics-Law Enforcement · closes November 9, 2026
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)National Institutes of Health · closes November 9, 2026
- Fiscal Year (FY) 2026 Funding Opportunity for Indian Tribes and Intertribal Consortia for Nonpoint Source Management Grants Under Clean Water Act Section 319Environmental Protection Agency · closes November 9, 2026
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)National Institutes of Health · closes November 9, 2026
- Capacity Building Grants for Non-Land-Grant Colleges of Agriculture ProgramNational Institute of Food and Agriculture · closes November 10, 2026
- PFE: Research Initiation in Engineering Formation (PFE: RIEF)U.S. National Science Foundation · closes November 10, 2026
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)National Institutes of Health · closes November 10, 2026
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)National Institutes of Health · closes November 10, 2026
